Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, announced that Co-Founder Dr. Vittorio Sebastiano will become its head of research.
[Turn Biotechnologies (Cision US, Inc.)]
